Full Text
EE233 Cost-Effectiveness of Ravulizumab Compared with Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in the Netherlands

Abstract

Authors

S Quist AJ Postma KJ Myren L de Jong MJ Postma

Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×